Skip to Content

Join the 'Navane' group to help and get support from people like you.

Navane News

Obamacare Covered More People With Mental Illness, Addictions

Posted 20 Jan 2017 by Drugs.com

FRIDAY, Jan. 20, 2017 – More Americans with mental illness and substance abuse disorders got health insurance after the Affordable Care Act was introduced, a new study shows. However, these patients still face significant barriers to treatment, the Johns Hopkins researchers added. "The Affordable Care Act has been very effective in reducing the uninsured rate in this vulnerable population, where there is a real need to get people into services," said study leader Brendan Saloner. He's an assistant professor in the department of health policy and management. "We got more people covered, but we didn't make dramatic progress in closing the under-treatment gap," Saloner said in a university news release. "We need to find ways to take the next step and ensure people are seeing the providers who can help them." For the study, researchers reviewed data from nearly 30,000 adults, aged 18 to ... Read more

Related support groups: Depression, Generalized Anxiety Disorder, Bipolar Disorder, Anxiety and Stress, Lexapro, Zoloft, Wellbutrin, Cymbalta, Effexor, Prozac, Opiate Dependence, Seroquel, Celexa, Major Depressive Disorder, Citalopram, Post Traumatic Stress Disorder, Paxil, Trazodone, Abilify, Sertraline

Are Too Many Young Americans Getting Antipsychotics for ADHD?

Posted 1 Jul 2015 by Drugs.com

WEDNESDAY, July 1, 2015 – A growing number of teens and young adults are being prescribed powerful antipsychotics, even though the medications aren't approved to treat two disorders – ADHD and depression – they are commonly used for, a new study shows. Researchers found that antipsychotic use rose among children aged 13 and older – from 1.1 percent in 2006 to nearly 1.2 percent in 2010. And among young adults – people aged 19 to 24 – antipsychotic use increased from 0.69 percent in 2006 to 0.84 percent in 2010. Of concern to some experts are the conditions for which many of these antipsychotic prescriptions are being written, namely attention-deficit hyperactivity disorder (ADHD) and depression. Currently, the U.S. Food and Drug Administration approves this class of drugs for psychiatric conditions such as psychosis, bipolar disorder, schizophrenia or impulsive aggression tied to ... Read more

Related support groups: Depression, Seroquel, Major Depressive Disorder, Abilify, Attention-Deficit Hyperactivity Disorder (ADHD), Lithium, Latuda, Zyprexa, Risperidone, Risperdal, Seroquel XR, Geodon, Quetiapine, Saphris, Oppositional Defiant Disorder, Olanzapine, Haldol, Dysthymia, Invega, Clozapine

Psychiatric Drugs More Often Prescribed in the South

Posted 1 Feb 2013 by Drugs.com

FRIDAY, Feb. 1 – Use of psychiatric medications is most prevalent in the southern United States and least prevalent in the West, according to a new U.S. study. Although people living in the West are the least likely to use antipsychotics, antidepressants and stimulants, the Yale researchers found that the drugs' use is 40 percent higher in a large section of the South than in other parts of the country. The study authors attributed this discrepancy to variations in local access to health care and marketing efforts within the pharmaceutical industry. "The geographic patterns we identify are striking and map onto the patterns found for a host of other medical conditions and treatments, from cognitive decline to bypass surgery," Marissa King, assistant professor of organizational behavior at the Yale School of Management, said in a school news release. "Our work suggests that access to ... Read more

Related support groups: Depression, Bipolar Disorder, Adderall, Lexapro, Zoloft, Wellbutrin, Cymbalta, Effexor, Prozac, Seroquel, Celexa, Phentermine, Citalopram, Vyvanse, Paxil, Trazodone, Abilify, Sertraline, Pristiq, Lithium

Older Antipsychotics May Work as Well as Newer Ones: Review

Posted 14 Aug 2012 by Drugs.com

TUESDAY, Aug. 14 – Newer, more expensive schizophrenia medications are not noticeably better than their older, cheaper counterparts, a new review suggests. Currently, 75 percent of U.S. adults who are prescribed antipsychotic medications take these second-generation drugs, which were developed largely due to concerns about side effects with their predecessors, experts noted. First-generation antipsychotics are also called typical antipsychotics. This class of drugs includes chlorpromazine (Thorazine), haloperidol (Haldol), perphenazine (Etrafon, Trilafon) and fluphenazine (Prolixin). Second-generation drugs, known as atypical, antipsychotics include risperidone (Risperdal), aripiprazole (Abilify), olanzapine (Zyprexa), quetiapine Fumarate (Seroquel) and ziprasidone (Geodon). There is a major cost difference between the two classes of drugs: For example, a month's supply of olanzapine ... Read more

Related support groups: Seroquel, Abilify, Latuda, Zyprexa, Risperidone, Risperdal, Seroquel XR, Geodon, Quetiapine, Saphris, Olanzapine, Haldol, Invega, Clozapine, Aripiprazole, Haloperidol, Compazine, Thorazine, Clozaril, Prochlorperazine

Schizophrenia Drugs May Spur Subtle Brain Tissue Loss

Posted 10 Feb 2011 by Drugs.com

MONDAY, Feb. 7 – The use of antipsychotic drugs to treat schizophrenia is associated with the loss of a small but measurable amount of brain tissue, a new study finds. It included 211 schizophrenia patients who each underwent an average of three MRI brain scans over 7.2 years, for a total of 674 scans in the study group. The researchers then examined how four factors affected changes in brain volume over time: illness duration, illness severity, substance abuse and treatment with antipsychotic drugs. Longer duration of illness and antipsychotic treatment were both associated with loss of brain tissue. Higher doses of antipsychotics were associated with overall brain tissue loss, reduced gray matter and progressive declines in white matter. Illness severity and substance abuse had little or no association with brain tissue changes, according to the study, published in the February issue ... Read more

Related support groups: Seroquel, Abilify, Lithium, Schizophrenia, Zyprexa, Risperidone, Risperdal, Seroquel XR, Geodon, Quetiapine, Saphris, Olanzapine, Haldol, Invega, Clozapine, Aripiprazole, Haloperidol, Compazine, Thorazine, Clozaril

FDA Medwatch Alert: Antipsychotics, Conventional and Atypical

Posted 16 Jun 2008 by Drugs.com

[Posted 06/16/2008] FDA notified healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. In April 2005, FDA notified healthcare professionals that patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death. Since issuing that notification, FDA has reviewed additional information that indicates the risk is also associated with conventional antipsychotics. Antipsychotics are not indicated for the treatment of dementia-related psychosis. The prescribing information for all antipsychotic drugs will now include the same information about this risk in a BOXED WARNING and the WARNINGS section.[June 16, 2008 - Information for Healthcare Professionals - FDA] Read more

Related support groups: Seroquel, Abilify, Zyprexa, Risperdal, Dementia, Geodon, Haldol, Invega, Compazine, Symbyax, Navane, Trilafon, Stelazine, Mellaril, Orap, Clopine, Loxitane, Moban, Permitil, Ormazine

Ask a Question

Further Information

Related Condition Support Groups

Psychosis, Schizophrenia

Navane Patient Information at Drugs.com